Clinical Trial Update: Everolimus trIal for Advanced prememopausaL Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for everolimus in advanced premenopausal metastatic breast cancer; status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN